Complications from use of sodium hyaluronate (Healonid) in anterior segment surgery.
Open Access
- 1 November 1982
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 66 (11) , 714-716
- https://doi.org/10.1136/bjo.66.11.714
Abstract
Sodium hyaluronate brings an important new advance to several techniques in ophthalmic microsurgery. Its use in 226 primary lens implantations [in humans] is described, it was safe and beneficial to both surgeon and patient. Apart from a 1 day rise of intraocular pressure, obviated by the routine use of timolol maleate or acetazolamide, in the dosage used it was free of complications.This publication has 8 references indexed in Scilit:
- The Effects of Timolol Maleate and Acetazolamide on the Rate of Aqueous Formation in Normal Human SubjectsAmerican Journal of Ophthalmology, 1982
- The Use of Sodium-Hyaluronate (Healon) in the Treatment of Retinal DetachmentOphthalmic Surgery, Lasers and Imaging Retina, 1981
- HealonR in anterior chamber lens implantationAmerican Intra-Ocular Implant Society Journal, 1981
- Protective role of Healon during lens implantation.1981
- Intracapsular and extracapsular technique of lens implantation with Healon®American Intra-Ocular Implant Society Journal, 1980
- The Use of Sodium Hyaluronate (Healon®) in Human Anterior Segment SurgeyOphthalmology, 1980
- Use of Na-hyaluronate in Anterior Segment Eye SurgeryAmerican Intra-Ocular Implant Society Journal, 1980
- Hyaluronic acid and replacement of vitreous and aqueous humor.1972